Two Sigma Investments
IDXX icon

Two Sigma Investments’s Idexx Laboratories IDXX Stock Holding History

Two Sigma Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,600
Closed -$4.35M – 3422
2021
Q4 		$4.35M Buy
6,600
+3,000
+83% +$1.88M 0.01% 1276
2021
Q3 		$2.24M Buy
+3,600
New +$2.42M 0.01% 1883
2021
Q2 		– Sell
-1,700
Closed -$832K – 4284
2021
Q1 		$832K Sell
1,700
-900
-35% -$451K ﹤0.01% 2484
2020
Q4 		$1.3M Sell
2,600
-1,400
-35% -$626K ﹤0.01% 1795
2020
Q3 		$1.57M Buy
+4,000
New +$1.48M 0.01% 1450
2020
Q2 		– Sell
-5,100
Closed -$1.24M – 3203
2020
Q1 		$1.24M Sell
5,100
-4,900
-49% -$1.28M 0.01% 1266
2019
Q4 		$2.61M Buy
10,000
+2,600
+35% +$685K 0.01% 1380
2019
Q3 		$2.01M Buy
7,400
+5,400
+270% +$1.5M 0.01% 1435
2019
Q2 		$551K Hold
2,000
– – ﹤0.01% 2423
2019
Q1 		$447K Sell
2,000
-2,000
-50% -$413K ﹤0.01% 2337
2018
Q4 		$744K Buy
+4,000
New +$820K ﹤0.01% 1840

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Two Sigma Investments's IDXX Position: Q2 2026 in Review

Two Sigma Investments increased its Idexx Laboratories (IDXX) stake by 8.4% in Q2 2026, buying an estimated $44.3K and bringing the position to 1,020 shares worth $537K. The position accounts for ﹤0.01% of the portfolio, ranked #4107.

Two Sigma Investments first reported a position in IDXX in Q2 2013 and has held it in 38 quarters since. The position peaked at $103M in Q1 2017. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Two Sigma Investments held 1,020 shares of Idexx Laboratories worth $537K as of Q2 2026.
  • Two Sigma Investments bought 79 Idexx Laboratories shares in Q2 2026, an estimated $44.3K.
  • Idexx Laboratories made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #4107 holding.
  • Two Sigma Investments first reported a position in Idexx Laboratories in Q2 2013 and has held it in 38 quarters since.
  • Two Sigma Investments's Idexx Laboratories position peaked at $103M in Q1 2017.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.